type here...

CATEGORIES

Clinical Trials

LATEST

123Page 3 of 3

TRENDING

EDITORS CHOICE

Cumulus Neuroscience Appoints Digital Health and Pharma Executive Aman Bhatti, MD as Chief Executive Officer

Medika Life -
Tapping AliveCor Senior Executive, Cumulus Signals Progression To A Global Healthcare Company; Dr. Bhatti To Lead Expansion of AI-Based Digital Biomarker Platform To Accelerate Patient Care and Drug Development in Neurology and Neuropsychiatry

The Defining Dance Between Empathy and GenAI in Health

Gil Bashe, Medika Life Editor -
Used wisely and to its fullest (positive) potential, augmented intelligence can extend the empathy quotient, making the wise healer more expansive. AI can unlock...

Forget Hype – Digital Therapeutic Data Show the Category Can be Held to High Clinical Standards

Gil Bashe, Medika Life Editor -
New Study Points to a Strong Possibility that Digital Health Can Advance Migraine Care Treatment

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

Medika Life -
The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories